Anticoagulation as thromboprophylaxis for atrial fibrillation: implications in the 'real world' and the need for risk stratification.
Lane
Deirdre A
DA
University Department of Medicine, City Hospital, Birmingham, UK.
Lip
Gregory Yh
GY
D000367:Age Factors; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D012307:Risk Factors; D015912:Thrombolytic Therapy / Q000009:adverse effects / Q000379:methods
D000925:Anticoagulants